Suppr超能文献

基于肠-肺轴的中药治疗新型冠状病毒肺炎

Herbal medicine in the treatment of COVID-19 based on the gut-lung axis.

作者信息

He Qiaoyu, Shi Yumeng, Tang Qian, Xing Hong, Zhang Han, Wang Mei, Chen Xiaopeng

机构信息

State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.

LU-European Center for Chinese Medicine and Natural Compounds, Institute of Biology, Leiden University/SU Biomedicine, Leiden, Netherlands.

出版信息

Acupunct Herb Med. 2022 Sep;2(3):172-183. doi: 10.1097/HM9.0000000000000038. Epub 2022 Dec 8.

Abstract

UNLABELLED

Respiratory symptoms are most commonly experienced by patients in the early stages of novel coronavirus disease 2019 (COVID-19). However, with a better understanding of COVID-19, gastrointestinal symptoms such as diarrhea, nausea, and vomiting have attracted increasing attention. The gastrointestinal tract may be a target organ of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The intestinal microecological balance is a crucial factor for homeostasis, including immunity and inflammation, which are closely related to COVID-19. Herbal medicine can restore intestinal function and regulate the gut flora structure. Herbal medicine has a long history of treating lung diseases from the perspective of the intestine, which is called the gut-lung axis. The physiological activities of guts and lungs influence each other through intestinal flora, microflora metabolites, and mucosal immunity. Microecological modulators are included in the diagnosis and treatment protocols for COVID-19. In this review, we demonstrate the relationship between COVID-19 and the gut, gut-lung axis, and the role of herbal medicine in treating respiratory diseases originating from the intestinal tract. It is expected that the significance of herbal medicine in treating respiratory diseases from the perspective of the intestinal tract could lead to new ideas and methods for treatment.

GRAPHICAL ABSTRACT

http://links.lww.com/AHM/A33.

摘要

未标注

呼吸道症状是新型冠状病毒肺炎(COVID-19)患者在疾病早期最常出现的症状。然而,随着对COVID-19的深入了解,腹泻、恶心和呕吐等胃肠道症状受到了越来越多的关注。胃肠道可能是严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的靶器官。肠道微生态平衡是维持体内稳态的关键因素,包括免疫和炎症,而这与COVID-19密切相关。草药可以恢复肠道功能并调节肠道菌群结构。从肠道论治肺病有着悠久的历史,这被称为肠-肺轴。肠道和肺部的生理活动通过肠道菌群、微生物代谢产物和黏膜免疫相互影响。微生态调节剂被纳入COVID-19的诊疗方案中。在本综述中,我们阐述了COVID-19与肠道、肠-肺轴之间的关系,以及草药在治疗源自肠道的呼吸道疾病中的作用。期望从肠道角度论治呼吸道疾病中草药的重要性能够带来新的治疗思路和方法。

图形摘要

http://links.lww.com/AHM/A33

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验